Market
The Market
• +$210B spent on cancer treatment in U.S. (2023), spend expected to exceed $245B by 2030 – American Assoc. for Cancer Research
• +1.9M new cancer cases diagnosed (2023) - American Cancer Society
• Cancer is the 2nd leading cause of death in U.S – Centers for Disease Control
• Medicare & Medicaid coverage & reimbursement increasing year-over-year.
• U.S. Market is underserved with only 49 PT facilities currently in operation –
Market need is 300 facilities to treat today’s cancer patients.
Market Strategy
We target sustainable, underserved markets with positive population and economic stability, providing cancer treatment to patients via refreferral from ALL regional health-care providers. We are not tied to just one network or provider. Direct to patient marketing is key.